Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘ArQule Inc. (NASDAQ:ARQL)’

drug factory, researcher,

ArQule, Inc. (ARQL)’s Liver Cancer Drug Fails: What’s Next?

ArQule, Inc. (NASDAQ:ARQL) took a real hit at the end of last week, as the company announced data from a late stage oncology trial. The data did not read......(read more)
ArQule, Inc. (NASDAQ:ARQL)

ArQule, Inc. (ARQL): Hedge Funds and Insiders Are Bearish, What Should You Do?

Is ArQule, Inc. (NASDAQ:ARQL) a buy here? The best stock pickers are reducing their bets on the stock. The number of bullish hedge fund bets were cut......(read more)
ArQule, Inc. (NASDAQ:ARQL)

Is ArQule, Inc. (ARQL) Going to Burn These Hedge Funds?: ShangPharma Corp (ADR) (SHP), OncoGenex Pharmaceuticals Inc (OGXI)

ArQule, Inc. (NASDAQ:ARQL) was in 13 hedge funds’ portfolio at the end of December. ARQL investors should pay attention to a decrease in hedge fund......(read more)